E. Perez, Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance, Molecular Cancer Therapeutics, vol.8, issue.8, pp.2086-95, 2009.
DOI : 10.1158/1535-7163.MCT-09-0366

F. Tsvetkov, A. Kulikova, F. Devred, E. Zerni?, D. Lafitte et al., Thermodynamics of calmodulin and tubulin binding to the vinca-alkaloid vinorelbine, Molecular Biology, vol.45, issue.4, pp.697-702, 2011.
DOI : 10.1134/S0026893311040108

P. Curmi, C. Noguès, S. Lachkar, N. Carelle, M. Gonthier et al., Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours, British Journal of Cancer, vol.82, issue.1, pp.142-50, 2000.
DOI : 10.1054/bjoc.1999.0891

R. Ghosh, G. Gu, E. Tillman, J. Yuan, Y. Wang et al., Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression. The Prostate. 1 juill, pp.1038-52, 2007.

D. Price, J. Ball, Z. Bahrani-mostafavi, J. Vachris, J. Kaufman et al., The Phosphoprotein Op18/Stathmin is Differentially Expressed in Ovarian Cancer, Cancer Investigation, vol.7, issue.8, pp.722-752, 2000.
DOI : 10.1016/S0968-0004(96)80013-2

T. Hemdan, M. Lindén, S. Lind, A. Namuduri, E. Sjöstedt et al., The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer, British Journal of Cancer, vol.5, issue.6, pp.1180-1187, 2014.
DOI : 10.1021/pr100712t

E. Alli, J. Yang, J. Ford, and W. Hait, Reversal of Stathmin-Mediated Resistance to Paclitaxel and Vinblastine in Human Breast Carcinoma Cells, Molecular Pharmacology, vol.71, issue.5, pp.1233-1273, 2007.
DOI : 10.1124/mol.106.029702

C. Iancu, S. Mistry, S. Arkin, and G. Atweh, Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle, Cancer Res. 1 juill, vol.60, issue.13, pp.3537-3578, 2000.

L. Martello, P. Verdier-pinard, H. Shen, L. He, K. Torres et al., Elevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an alpha-tubulin mutation, Cancer Res. 15 mars, vol.63, issue.6, pp.1207-1220, 2003.

S. Mistry, A. Bank, and G. Atweh, Synergistic Antiangiogenic Effects of Stathmin Inhibition and Taxol Exposure, Molecular Cancer Research, vol.5, issue.8, pp.773-82, 2007.
DOI : 10.1158/1541-7786.MCR-06-0290

L. Cassimeris, The oncoprotein 18/stathmin family of microtubule destabilizers, Current Opinion in Cell Biology, vol.14, issue.1, pp.18-24, 2002.
DOI : 10.1016/S0955-0674(01)00289-7

T. Manna, D. Thrower, H. Miller, P. Curmi, and L. Wilson, Stathmin Strongly Increases the Minus End Catastrophe Frequency and Induces Rapid Treadmilling of Bovine Brain Microtubules at Steady State in Vitro, Journal of Biological Chemistry, vol.281, issue.4, pp.2071-2079, 2006.
DOI : 10.1074/jbc.M510661200

F. Devred, P. Tsvetkov, P. Barbier, D. Allegro, S. Horwitz et al., Stathmin/Op18 is a novel mediator of vinblastine activity, FEBS Letters, vol.46, issue.17, p.18588888, 2008.
DOI : 10.1016/j.febslet.2008.06.035

P. Tsvetkov, P. Barbier, G. Breuzard, V. Peyrot, and F. Devred, Microtubule-Associated Proteins and Tubulin Interaction by Isothermal Titration Calorimetry, Methods Cell Biol, vol.115, pp.283-302, 2013.
DOI : 10.1016/B978-0-12-407757-7.00018-9
URL : https://hal.archives-ouvertes.fr/hal-01478645

P. Tsvetkov, A. Makarov, S. Malesinski, V. Peyrot, and F. Devred, New insights into tau???microtubules interaction revealed by isothermal titration calorimetry, Biochimie, vol.94, issue.3, pp.916-925, 2012.
DOI : 10.1016/j.biochi.2011.09.011

P. Barbier, P. Tsvetkov, G. Breuzard, and F. Devred, Deciphering the molecular mechanisms of anti-tubulin plant derived drugs, Phytochemistry Reviews, vol.37, issue.19, pp.157-69, 2014.
DOI : 10.1007/s11101-013-9302-8
URL : https://hal.archives-ouvertes.fr/hal-01470519

D. Braguer, J. Barret, H. Mcdaid, and A. Kruczynski, Antitumor Activity of Vinflunine: Effector Pathways and Potential for Synergies, Seminars in Oncology, vol.35, issue.3, p.18538174, 2008.
DOI : 10.1053/j.seminoncol.2008.01.011

S. Honnappa, B. Cutting, W. Jahnke, J. Seelig, and M. Steinmetz, Thermodynamics of the Op18/Stathmin-Tubulin Interaction, Journal of Biological Chemistry, vol.278, issue.40, pp.38926-38960, 2003.
DOI : 10.1074/jbc.M305546200

K. Gupta, C. Li, A. Duan, E. Alberico, O. Kim et al., Mechanism for the catastrophe-promoting activity of the microtubule destabilizer Op18/stathmin, Proceedings of the National Academy of Sciences, vol.110, issue.51, pp.20449-54, 2013.
DOI : 10.1073/pnas.1309958110

M. Jordan, S. Horwitz, S. Lobert, and J. Correia, Exploring the Mechanisms of Action of the Novel Microtubule Inhibitor Vinflunine, Seminars in Oncology, vol.35, issue.3, pp.6-12, 2008.
DOI : 10.1053/j.seminoncol.2008.01.009

S. Lobert and J. Correia, Energetics of vinca alkaloid interactions with tubulin, Methods Enzymol, vol.323, pp.77-103, 2000.
DOI : 10.1016/S0076-6879(00)23362-4

B. Gigant, C. Wang, R. Ravelli, F. Roussi, M. Steinmetz et al., Structural basis for the regulation of tubulin by vinblastine, Nature, vol.60, issue.7041, pp.519-541, 2005.
DOI : 10.1038/nature02197

K. Nishio, T. Nakamura, Y. Koh, F. Kanzawa, T. Tamura et al., Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells, Cancer, vol.27, issue.8, pp.1494-1503, 2001.
DOI : 10.1002/1097-0142(20010415)91:8<1494::AID-CNCR1157>3.0.CO;2-7

T. Arakawa and S. Timasheff, The mechanism of action of Na glutamate, lysine HCl, and piperazine-N,N'- bis(2-ethanesulfonic acid) in the stabilization of tubulin and microtubule formation, J Biol Chem. 25 avr, vol.259, issue.8, pp.4979-86, 1984.

E. Alli, J. Bash-babula, J. Yang, and W. Hait, Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer, Cancer Res. 1 déc, vol.62, issue.23, pp.6864-6873, 2002.

H. Werner, J. Trovik, M. Halle, E. Wik, L. Akslen et al., Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer, PLoS ONE, vol.25, issue.2, p.24587245
DOI : 10.1371/journal.pone.0090141.t001

X. Lin, Y. Liao, J. Xie, S. Liu, L. Su et al., Op18/Stathmin Is Involved in the Resistance of Taxol Among Different Epithelial Carcinoma Cell Lines, Cancer Biotherapy & Radiopharmaceuticals, vol.29, issue.9, pp.376-86, 2014.
DOI : 10.1089/cbr.2014.1649

W. Feng, X. Xiaoyan, Y. Xuan, L. Xiangke, Y. Zichang et al., Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxel, Cancer Gene Therapy, vol.32, issue.3, 2015.
DOI : 10.3109/00365521.2012.683042

S. Honnappa, W. Jahnke, J. Seelig, and M. Steinmetz, Control of Intrinsically Disordered Stathmin by Multisite Phosphorylation, Journal of Biological Chemistry, vol.281, issue.23, pp.16078-83, 2006.
DOI : 10.1074/jbc.M513524200

T. Manna, D. Thrower, S. Honnappa, M. Steinmetz, and L. Wilson, Regulation of Microtubule Dynamic Instability in Vitro by Differentially Phosphorylated Stathmin, M900343200 PMID, pp.15640-15649, 2009.
DOI : 10.1074/jbc.M900343200

P. Curmi, O. Gavet, E. Charbaut, S. Ozon, S. Lachkar-colmerauer et al., Stathmin and its Phosphoprotein Family. General Properties, Biochemical and Functional Interaction with Tubulin., Cell Structure and Function, vol.24, issue.5, pp.345-57, 1999.
DOI : 10.1247/csf.24.345